Eli Lilly rises after President Donald Trump announces a 100% tariff on drug products from companies not building manufacturing plants in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback